RAYCARE LIMITED

Company Registration Number:
05312918 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

RAYCARE LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2023

Balance sheet
Notes

RAYCARE LIMITED

Balance sheet

As at 31 March 2023


Notes

2023

2022


£

£
Fixed assets
Tangible assets: 3 4,298,924 4,266,787
Total fixed assets: 4,298,924 4,266,787
Current assets
Debtors:   278,369 266,654
Cash at bank and in hand: 205,153 269,703
Total current assets: 483,522 536,357
Creditors: amounts falling due within one year:   (217,382) (136,237)
Net current assets (liabilities): 266,140 400,120
Total assets less current liabilities: 4,565,064 4,666,907
Creditors: amounts falling due after more than one year:   (2,501,220) (2,660,218)
Total net assets (liabilities): 2,063,844 2,006,689
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 2,063,744 2,006,589
Shareholders funds: 2,063,844 2,006,689

The notes form part of these financial statements

RAYCARE LIMITED

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 25 May 2023
and signed on behalf of the board by:

Name: Raymond Weiniger
Status: Director

The notes form part of these financial statements

RAYCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

RAYCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

2. Employees

2023 2022
Average number of employees during the period 89 91

RAYCARE LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Tangible Assets

Total
Cost £
At 01 April 2022 5,237,019
Additions 95,163
At 31 March 2023 5,332,182
Depreciation
At 01 April 2022 970,232
Charge for year 63,026
At 31 March 2023 1,033,258
Net book value
At 31 March 2023 4,298,924
At 31 March 2022 4,266,787